TherapeuticsMD (TXMD) Tops Q3 EPS by 2c

TherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
• Carnival shares drop despite earnings beat on weak guidance